Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MT-1303 in moderate to severe chronic plaque psoriasis
NCT01987843Phase 2Completed
- Sponsor
- Mitsubishi Tanabe Pharma Corporation
- Start
- Sep 2013
- Primary completion
- Sep 2014
- Modality
- Small Molecules
- Countries
- 8
01
Overview
A Phase 2 trial of amiselimod in plaque psoriasis, sponsored by Mitsubishi Tanabe Pharma Corporation. Started Sep 2013; status: completed.
02
Drugs
amiselimod
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on NCT01987843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01987843.